Contact this trialFirst, we need to learn more about you.
Anti-tumor antibiotic
Ixazomib + Chemotherapy for Kidney Cancer
Recruiting3 awardsPhase 2
Houston, Texas
This trial is studying a combination of drugs to treat kidney cancer. Ixazomib may stop the growth of tumor cells by blocking some enzymes needed for cell growth. Gemcitabine and doxorubicin work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service